Information was received from a healthcare provider (hcp) via a company representative regarding a patient receiving baclofen (2000 mcg/ml at 309.5 mcg/day) via an implanted pump.The indication for pump use was intractable spasticity.It was reported that per the managing practice, the pump was empty when performing the scheduled refill on (b)(6) 2021.The expected volume was 15.2 ml; however, when they tried to pull the drug from the pump it was empty.The patient complained of itching, tiredness, and increased spasticity prior to coming in for the refill.The pump was refilled that day and no changes were made to the pump settings.The patient¿s symptoms eventually went away.A dye study was ordered and performed on (b)(6) 2021.The dye study was successful.There were no issues.An mri was performed on (b)(6) 2021 and those results were unknown.It was noted that the patient normally came in on ce very 6 months for refills.According to the pump logs, there was an update done on (b)(6) 2020, but what exactly was done on that date was unknown.The refill prior to that was (b)(6) 2020.The issue was noted to be resolved at the time of the report, and it was indicated that the hcp had no further information to provide regarding the event.
|